Panel Japan

Panel Japan Co., Ltd. is a Tokyo-based biotechnology company dedicated to advancing cancer genomic medicine through specialized genetic analysis services. Founded in 2018, the company operates as a high-throughput sequencing center that processes cancer gene panels to identify therapeutic targets for personalized oncology. They are a key partner in the clinical implementation of the OncoGuide NCC Oncopanel System, providing the bioinformatics and laboratory infrastructure necessary for comprehensive genomic profiling. Beyond diagnostics, Panel Japan supports clinical trials and academic research by offering tailored genomic data analysis and consulting services. The company's mission is to bridge the gap between genomic research and clinical practice in Japan.